Yet another shareholder sues Covidien and its leaders, accusing them of short-changing investors in the $43 billion acquisition by Medtronic.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qxEcts
Cap comentari:
Publica un comentari a l'entrada